跳至主要内容
临床试验/IRCT20161203031212N3
IRCT20161203031212N3已完成3 期

The effects of alpha-lipoic acid supplementation on oxidative stress status, inflammatory markers, VCAM-I serum levels, lactate and clinical symptoms in women with migraine.

Esfahan University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 50 years(—)
性别
Female

入选标准

  • Willingness to participation in the study.
  • Diagnosis of migraine by a neurologist based on ICHD-3 criteria.
  • Age 20 to 50 years.
  • Non-menopausal women.

排除标准

  • History of any allergies, intolerances or adverse drug reactions to the supplement.
  • Pregnancy and lactation.
  • History of intestinal bypass.
  • Follow a special diet for the past 6 months.
  • Smoking or alcohol.
  • Take any supplements.
  • Cardiovascular disease, diabetes, liver, kidney, thyroid, malignant disease and other neurological disorders are diagnosed based on the patient interview.
  • Start taking the new drug within the last 1 month

研究者

相似试验